|
Jun 29
|
Investors in Royalty Pharma (NASDAQ:RPRX) have seen respectable returns of 40% over the past year
|
|
Jun 27
|
5 Revealing Analyst Questions From Royalty Pharma’s Q1 Earnings Call
|
|
Jun 2
|
Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock?
|
|
Feb 12
|
Royalty Pharma Announces R&D Funding Collaboration With Biogen
|
|
Feb 12
|
Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...
|
|
Feb 11
|
Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates
|
|
Feb 11
|
Royalty Pharma Reports Q4 and Full Year 2024 Results
|
|
Feb 10
|
Royalty Pharma Earnings: What To Look For From RPRX
|